Morabaha Marina Financing Co. (MRNA) posted a net profit (excluding minority interest) of SAR 1.2 million in the first nine months of 2025, a fall of 94% from SAR 20 million in the prior-year period.
| Item | 9m 2024 | 9m 2025 | Change |
|---|---|---|---|
| Net income from finance commissions | 95.45 | 125.01 | 31.0 % |
| Net Income | 19.98 | 1.24 | (93.8 %) |
| Average Shares | 71.43 | 71.43 | - |
| Earnings Per Share before unusual items (Riyals) | 0.28 | 0.02 | (93.8 %) |
| EPS (Riyal) | 0.28 | 0.02 | (93.8 %) |
Net profit before excluding minority interest reached SAR 3.2 million for the nine-month period, from SAR 14.7 million a year earlier.
The profit decline is attributed to an increase in general expenses and impairment losses, along with continued losses of the subsidiary (LOOP).
However, revenue increased by 19.48% to SAR 164.08 million, compared to SAR 137.33 million in the corresponding period of the previous year, mainly due to an increase in new financing contracts from Q4 2024 through Q3 2025.
| Item | Q3 2024 | Q3 2025 | Change |
|---|---|---|---|
| Net income from finance commissions | 32.14 | 41.73 | 29.8 % |
| Net Income | 8.20 | (1.73) | (121.1 %) |
| Average Shares | 71.43 | 71.43 | - |
| Earnings Per Share before unusual items (Riyal) | 0.11 | (0.02) | (121.1 %) |
| EPS (Riyal) | 0.11 | (0.02) | (121.1 %) |
| Item | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Net income from finance commissions | 43.06 | 41.73 | (3.1 %) |
| Net Income | (1.24) | (1.73) | (39.4 %) |
| Average Shares | 71.43 | 71.43 | - |
| Earnings Per Share before unusual items (Riyal) | (0.02) | (0.02) | (39.4 %) |
| EPS (Riyal) | (0.02) | (0.02) | (39.4 %) |
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: